LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 103 of 166
Next
>>
>
2551 to 2575 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	GSK 690693	0.04	uM	LJP5	72	hr	1334	3452	4033	0.8554	0.8125
BT-20	GSK 690693	0.12	uM	LJP5	72	hr	1334	3529	4033	0.8740	0.8358
BT-20	GSK 690693	0.37	uM	LJP5	72	hr	1334	3024	4033	0.7496	0.6685
BT-20	GSK 690693	1.11	uM	LJP5	72	hr	1334	2757	4033	0.6837	0.5753
BT-20	GSK 690693	3.33	uM	LJP5	72	hr	1334	2401	4033	0.5951	0.4438
BT-20	GSK 690693	10	uM	LJP5	72	hr	1334	2183	4033	0.5414	0.3609
BT-20	SNS-032	0.04	uM	LJP6	72	hr	1334	3780	3925	0.9632	0.9524
BT-20	SNS-032	0.12	uM	LJP6	72	hr	1334	2372	3925	0.6047	0.4445
BT-20	SNS-032	0.37	uM	LJP6	72	hr	1334	752	3925	0.1919	-0.3088
BT-20	SNS-032	1.11	uM	LJP6	72	hr	1334	423	3925	0.1078	-0.5225
BT-20	SNS-032	3.33	uM	LJP6	72	hr	1334	394	3925	0.1004	-0.5434
BT-20	SNS-032	10	uM	LJP6	72	hr	1334	422	3925	0.1076	-0.5238
BT-20	Afatinib	0.04	uM	LJP6	72	hr	1334	3050	3925	0.7774	0.7008
BT-20	Afatinib	0.12	uM	LJP6	72	hr	1334	3247	3925	0.8273	0.7705
BT-20	Afatinib	0.37	uM	LJP6	72	hr	1334	3305	3925	0.8421	0.7906
BT-20	Afatinib	1.11	uM	LJP6	72	hr	1334	3442	3925	0.8768	0.8370
BT-20	Afatinib	3.33	uM	LJP6	72	hr	1334	3377	3925	0.8604	0.8152
BT-20	Afatinib	10	uM	LJP6	72	hr	1334	2081	3925	0.5307	0.3294
BT-20	GSK1904529A	0.04	uM	LJP6	72	hr	1334	3236	3925	0.8245	0.7667
BT-20	GSK1904529A	0.12	uM	LJP6	72	hr	1334	3753	3925	0.9565	0.9435
BT-20	GSK1904529A	0.37	uM	LJP6	72	hr	1334	3680	3925	0.9377	0.9189
BT-20	GSK1904529A	1.11	uM	LJP6	72	hr	1334	3796	3925	0.9674	0.9565
BT-20	GSK1904529A	3.33	uM	LJP6	72	hr	1334	3893	3925	0.9921	0.9897
BT-20	GSK1904529A	10	uM	LJP6	72	hr	1334	3781	3925	0.9631	0.9520
BT-20	Linsitinib	0.04	uM	LJP5	72	hr	1334	3462	4033	0.8589	0.8180

|<
<<
Previous
Page 103 of 166
Next
>>
>
2551 to 2575 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)